CJC 1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH). It is studied in endocrine and muscle repair models for its ability to stimulate pulsatile GH release and increase circulating IGF-1 levels over an extended period. The DAC modification allows CJC 1295 to bind to albumin, enhancing half-life and minimizing the frequency of administration compared to shorter GHRH peptides.
Purity:
≥99% (HPLC Verified)
Format:
Lyophilized powder
Storage:
Store at -20°C, protect from light and moisture
Solvent:
Bacteriostatic Water
Concentration:
Add 1mL BAC water = 5mg/mL solution
Stability:
Store reconstituted vial at 2°C–8°C and use within 30 days
Dose:
1mg = 0.2mL = ~20 units (using 100iu insulin syringe)
Frequency:
2–3x weekly; studied in long-term GH stimulation models
Dosing based on 5mg/mL concentration. For laboratory reference use only.
Research Use:
Not for human or veterinary use. For educational and laboratory study only.
Qualified Use:
For licensed researchers and laboratory professionals
Scientific Basis:
Information reflects GHRH analog activity and albumin-binding half-life extension models
Reminder:
Do not misbrand, misuse, or misrepresent this compound
J Clin Endocrinol Metab (2006):
Disclaimer
CJC 1295 with DAC is a research compound not approved for medical use. AlphaBoost supplies this product for research and reference purposes only. It is not for human or veterinary use.
Reviews
There are no reviews yet.